- What: The Access Strategy Framework allows Novartis to work with a portfolio of access models that make up its access strategy and are tailored to the specific needs of patients in each income segment.
- Objective: It aims to guide the systematic and collaborative development of equitable and affordable access-solutions targeted to different income segments.
- Details: Novartis wants to enter the middle-, lower- and low-income segments with scalable and replicable inclusive access solutions.
- Scope: It is a global approach that is applied by all business divisions and targets all disease areas where Novartis is active.
The Novartis Access Strategy Framework is being adopted by all three company divisions (Innovative Medicines, Alcon and Sandoz). The Framework guides the systematic and collaborative development of equitable and affordable access solutions, targeted to serve all segments of the socioeconomic pyramid. This has resulted in improved tools to support decision making processes (e.g., equitable pricing software) as well as broader and systematic implementation of local brands for emerging markets. Novartis access to healthcare initiatives are embedded in Novartis’ business divisions, and each division has an access-to-healthcare implementation plan that aligns with its business.
The rationale for using the global income pyramid as a starting point for Novartis’ access-to-healthcare strategy is that the business models of multinational companies are typically tailored to serve the needs of patients at the top of the income pyramid that have either sufficient resources for self-pay or are adequately insured. Novartis wants to go beyond this and enter the middle-, lower- and low-income segments with scalable and replicable inclusive access solutions, as the company foresees interesting business opportunities and growth potential particularly in the middle-income segment. These income segments serve as a proxy to consider affordability of products, but they are typically also indicative of the extent to which other barriers to access are relevant. That is, in lower-income segments the healthcare system is not well developed, which has a bearing on the availability of products and accessibility of services, patient awareness is low and often quality problems exist.
This approach allows Novartis to work with a portfolio of access models that are all important elements of its access strategy and are tailored to the specific needs of patients in each income segment.